Siglec-7 restores β-cell function and survival and reduces inflammation in pancreatic islets from patients with diabetes
Gitanjali Dharmadhikari(Royal Netherlands Academy of Arts and Sciences), Kathrin Maedler(University of Bremen)
Cited by 47
Related Papers
Aging Correlates With Decreased β-Cell Proliferative Capacity and Enhanced Sensitivity to Apoptosis
|Diabetes|2006|157
Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival
|Diabetologia|2009|90
Neratinib protects pancreatic beta cells in diabetes
|Nature Communications|2019|64